Wells Fargo
BBNX

Wells Fargo’s Beta Bionics BBNX Stock Holding History

Wells Fargo’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$557K Buy
35,577
+14,055
+65% +$167K ﹤0.01% 4536
2026
Q1 		$216K Sell
21,522
-28,790
-57% -$426K ﹤0.01% 4663
2025
Q4 		$1.53M Buy
50,312
+18,358
+57% +$490K ﹤0.01% 3649
2025
Q3 		$635K Buy
31,954
+16,934
+113% +$298K ﹤0.01% 4125
2025
Q2 		$219K Sell
15,020
-800
-5% -$11.3K ﹤0.01% 4721
2025
Q1 		$194K Buy
+15,820
New +$295K ﹤0.01% 4726

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Wells Fargo's BBNX Position: Q2 2026 in Review

Wells Fargo increased its Beta Bionics (BBNX) stake by 65% in Q2 2026, buying an estimated $167K and bringing the position to 35,577 shares worth $557K. The position accounts for ﹤0.01% of the portfolio, ranked #4536.

Wells Fargo first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.53M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Wells Fargo held 35,577 shares of Beta Bionics worth $557K as of Q2 2026.
  • Wells Fargo bought 14,055 Beta Bionics shares in Q2 2026, an estimated $167K.
  • Beta Bionics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4536 holding.
  • Wells Fargo first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Wells Fargo's Beta Bionics position peaked at $1.53M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.